Analyst Ratings For ABIOMED (NASDAQ:ABMD)
Today, Piper Jaffray Companies reiterated its Overweight rating on ABIOMED (NASDAQ:ABMD) with a price target of $160.00.
There are 1 hold rating, 6 buy ratings on the stock.
The current consensus rating on ABIOMED (NASDAQ:ABMD) is Buy (Score: 2.86) with a consensus target price of $152.50 per share, a potential 6.67% upside.
Some recent analyst ratings include
- 7/27/2017-Piper Jaffray Companies Reiterated Rating of Overweight.
- 7/10/2017-Morgan Stanley Reiterated Rating of Equal Weight.
- 6/8/2017-William Blair Reiterated Rating of Outperform .
- 1/8/2017-BTIG Research Reiterated Rating of Buy.
- 12/6/2016-Guggenheim initiated coverage with a Buy rating.
Recent Insider Trading Activity For ABIOMED (NASDAQ:ABMD)
ABIOMED (NASDAQ:ABMD) has insider ownership of 7.00% and institutional ownership of 90.77%.
- On 5/16/2017 Michael G Howley, VP, sold 18,279 with an average share price of $133.56 per share and the total transaction amounting to $2,441,343.24. View SEC Filing
- On 5/8/2017 David M Weber, COO, sold 21,250 with an average share price of $130.89 per share and the total transaction amounting to $2,781,412.50. View SEC Filing
- On 5/8/2017 Dorothy E Puhy, Director, sold 13,500 with an average share price of $131.12 per share and the total transaction amounting to $1,770,120.00. View SEC Filing
- On 5/8/2017 Michael G Howley, VP, sold 600 with an average share price of $132.84 per share and the total transaction amounting to $79,704.00. View SEC Filing
- On 3/17/2017 Andrew J Greenfield, VP, sold 10,000 with an average share price of $124.00 per share and the total transaction amounting to $1,240,000.00. View SEC Filing
- On 12/13/2016 Dorothy E Puhy, Director, sold 8,000 with an average share price of $120.00 per share and the total transaction amounting to $960,000.00. View SEC Filing
- On 11/30/2016 Eric A Md Rose, Director, sold 8,000 with an average share price of $110.81 per share and the total transaction amounting to $886,480.00. View SEC Filing
Recent Trading Activity for ABIOMED (NASDAQ:ABMD)
Shares of ABIOMED closed the previous trading session at 142.97 down -2.11 -1.45% with 686,894 shares trading hands.